RxDoctor Payments Data

Karen Bennett Baker

Psychiatric/Mental Health · Somerset, KYNPI 1558594838

Payments from drug & device makers

$852in general payments, 2019–2025

Across 47 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$204
  • Alkermes, Inc.$165
  • Axsome Therapeutics, Inc.$142
  • E.r. Squibb & Sons, L.L.C.$90
  • Otsuka America Pharmaceutical, Inc.$65
  • Vanda Pharmaceuticals Inc.$50
  • plus $136 from 4 others

What the payments were for

  • Food & beverage$82897%
  • Education$243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$852 in reported general payments places this provider in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$7,604
Medicare patients
13
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl29$30,950
VyvanseLisdexamfetamine Dimesylate12$4,472
Paliperidone ErPaliperidone12$3,303
Vilazodone Hcl24$2,361
Aripiprazole28$1,315
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl68$1,256
Quetiapine Fumarate ErQuetiapine Fumarate34$1,133
Atomoxetine Hcl14$1,124
Buspirone Hcl134$946
Doxepin Hcl28$852
Duloxetine Hcl52$729
Olanzapine43$594
Trazodone Hcl97$484
Hydroxyzine Pamoate56$456
Divalproex Sodium ErDivalproex Sodium14$412

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$47$30,95029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →